200 related articles for article (PubMed ID: 16407265)
1. Molecular mechanism of alpha 1(I)-osteogenesis imperfecta/Ehlers-Danlos syndrome: unfolding of an N-anchor domain at the N-terminal end of the type I collagen triple helix.
Makareeva E; Cabral WA; Marini JC; Leikin S
J Biol Chem; 2006 Mar; 281(10):6463-70. PubMed ID: 16407265
[TBL] [Abstract][Full Text] [Related]
2. Mutations near amino end of alpha1(I) collagen cause combined osteogenesis imperfecta/Ehlers-Danlos syndrome by interference with N-propeptide processing.
Cabral WA; Makareeva E; Colige A; Letocha AD; Ty JM; Yeowell HN; Pals G; Leikin S; Marini JC
J Biol Chem; 2005 May; 280(19):19259-69. PubMed ID: 15728585
[TBL] [Abstract][Full Text] [Related]
3. Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.
Cabral WA; Makareeva E; Letocha AD; Scribanu N; Fertala A; Steplewski A; Keene DR; Persikov AV; Leikin S; Marini JC
Hum Mutat; 2007 Apr; 28(4):396-405. PubMed ID: 17206620
[TBL] [Abstract][Full Text] [Related]
4. Helical mutations in type I collagen that affect the processing of the amino-propeptide result in an Osteogenesis Imperfecta/Ehlers-Danlos Syndrome overlap syndrome.
Malfait F; Symoens S; Goemans N; Gyftodimou Y; Holmberg E; López-González V; Mortier G; Nampoothiri S; Petersen MB; De Paepe A
Orphanet J Rare Dis; 2013 May; 8():78. PubMed ID: 23692737
[TBL] [Abstract][Full Text] [Related]
5. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood.
Malfait F; Symoens S; De Backer J; Hermanns-Lê T; Sakalihasan N; Lapière CM; Coucke P; De Paepe A
Hum Mutat; 2007 Apr; 28(4):387-95. PubMed ID: 17211858
[TBL] [Abstract][Full Text] [Related]
6. Type I collagen triplet duplication mutation in lethal osteogenesis imperfecta shifts register of alpha chains throughout the helix and disrupts incorporation of mutant helices into fibrils and extracellular matrix.
Cabral WA; Mertts MV; Makareeva E; Colige A; Tekin M; Pandya A; Leikin S; Marini JC
J Biol Chem; 2003 Mar; 278(12):10006-12. PubMed ID: 12538651
[TBL] [Abstract][Full Text] [Related]
7. Substitution of serine for glycine 883 in the triple helix of the pro alpha 1 (I) chain of type I procollagen produces osteogenesis imperfecta type IV and introduces a structural change in the triple helix that does not alter cleavage of the molecule by procollagen N-proteinase.
Lightfoot SJ; Atkinson MS; Murphy G; Byers PH; Kadler KE
J Biol Chem; 1994 Dec; 269(48):30352-7. PubMed ID: 7982948
[TBL] [Abstract][Full Text] [Related]
8. Substitutions for arginine at position 780 in triple helical domain of the α1(I) chain alter folding of the type I procollagen molecule and cause osteogenesis imperfecta.
Makareeva E; Sun G; Mirigian LS; Mertz EL; Vera JC; Espinoza NA; Yang K; Chen D; Klein TE; Byers PH; Leikin S
PLoS One; 2018; 13(7):e0200264. PubMed ID: 29990383
[TBL] [Abstract][Full Text] [Related]
9. A novel arginine-to-cysteine substitution in the triple helical region of the alpha1(I) collagen chain in a family with an osteogenesis imperfecta/Ehlers-Danlos phenotype.
Lund A; Joensen F; Christensen E; Dunø M; Skovby F; Schwartz M
Clin Genet; 2008 Jan; 73(1):97-101. PubMed ID: 18028452
[No Abstract] [Full Text] [Related]
10. In vivo and in vitro noncovalent association of excised alpha 1 (I) amino-terminal propeptides with mutant pN alpha 2(I) collagen chains in native mutant collagen in a case of Ehlers-Danlos syndrome, type VII.
Wirtz MK; Keene DR; Hori H; Glanville RW; Steinmann B; Rao VH; Hollister DW
J Biol Chem; 1990 Apr; 265(11):6312-7. PubMed ID: 2318855
[TBL] [Abstract][Full Text] [Related]
11. Met>Val substitution in a highly conserved region of the pro-alpha1(I) collagen C-propeptide domain causes alternative splicing and a mild EDS/OI phenotype.
Symoens S; Nuytinck L; Legius E; Malfait F; Coucke PJ; De Paepe A
J Med Genet; 2004 Jul; 41(7):e96. PubMed ID: 15235039
[No Abstract] [Full Text] [Related]
12. Sequence environment of mutation affects stability and folding in collagen model peptides of osteogenesis imperfecta.
Bryan MA; Cheng H; Brodsky B
Biopolymers; 2011; 96(1):4-13. PubMed ID: 20235194
[TBL] [Abstract][Full Text] [Related]
13. Recombinant collagen studies link the severe conformational changes induced by osteogenesis imperfecta mutations to the disruption of a set of interchain salt bridges.
Xu K; Nowak I; Kirchner M; Xu Y
J Biol Chem; 2008 Dec; 283(49):34337-44. PubMed ID: 18845533
[TBL] [Abstract][Full Text] [Related]
14. Compound phenotype of osteogenesis imperfecta and Ehlers-Danlos syndrome caused by combined mutations in
Lin Z; Zeng J; Wang X
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31239369
[TBL] [Abstract][Full Text] [Related]
15. Changes in thermal stability and microunfolding pattern of collagen helix resulting from the loss of alpha2(I) chain in osteogenesis imperfecta murine.
Kuznetsova NV; McBride DJ; Leikin S
J Mol Biol; 2003 Aug; 331(1):191-200. PubMed ID: 12875845
[TBL] [Abstract][Full Text] [Related]
16. Osteogenesis imperfecta missense mutations in collagen: structural consequences of a glycine to alanine replacement at a highly charged site.
Xiao J; Cheng H; Silva T; Baum J; Brodsky B
Biochemistry; 2011 Dec; 50(50):10771-80. PubMed ID: 22054507
[TBL] [Abstract][Full Text] [Related]
17. Disruption of one intra-chain disulphide bond in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I procollagen permits slow assembly and secretion of overmodified, but stable procollagen trimers and results in mild osteogenesis imperfecta.
Pace JM; Kuslich CD; Willing MC; Byers PH
J Med Genet; 2001 Jul; 38(7):443-9. PubMed ID: 11432962
[TBL] [Abstract][Full Text] [Related]
18. COL1-related overlap disorder: A novel connective tissue disorder incorporating the osteogenesis imperfecta/Ehlers-Danlos syndrome overlap.
Morlino S; Micale L; Ritelli M; Rohrbach M; Zoppi N; Vandersteen A; Mackay S; Agolini E; Cocciadiferro D; Sasaki E; Madeo A; Ferraris A; Reardon W; Di Rocco M; Novelli A; Grammatico P; Malfait F; Mazza T; Hakim A; Giunta C; Colombi M; Castori M
Clin Genet; 2020 Mar; 97(3):396-406. PubMed ID: 31794058
[TBL] [Abstract][Full Text] [Related]
19. Predicting the clinical lethality of osteogenesis imperfecta from collagen glycine mutations.
Bodian DL; Madhan B; Brodsky B; Klein TE
Biochemistry; 2008 May; 47(19):5424-32. PubMed ID: 18412368
[TBL] [Abstract][Full Text] [Related]
20. Nuclear magnetic resonance shows asymmetric loss of triple helix in peptides modeling a collagen mutation in brittle bone disease.
Liu X; Kim S; Dai QH; Brodsky B; Baum J
Biochemistry; 1998 Nov; 37(44):15528-33. PubMed ID: 9799516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
